Class IIITerminated in FDA datasetRecall initiated Dec 22, 2023

Solgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle.…

Recalling firm: Nestle Product Technology Center - Nestle Health Science

Why it was recalled

Nestle Health Science has initiated a recall of Solgar Glucosamine Chondroitin, 120 Tablets, in Glass bottle, 12 bottles per case because of error during packaging in which a A…

Historical recall record. This is not a new recall announcement. “Terminated” describes the FDA recall process; it does not certify that an individual package is safe. FDA termination date: Mar 26, 2024.

Check your package

Compare the exact product and package details with the label you have.

ProductSolgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle. Glass Bottle, 12 per Case, Store at room temperature . Product Number -1319

FDA code information

Lot/Unit Numbers: 3250UM0704 UPC Codes: 041260351211

Match the product, package size, and code together. A missing match does not guarantee safety.

Full FDA record and distribution details

Original product description

Solgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle. Glass Bottle, 12 per Case, Store at room temperature . Product Number -1319

Original FDA recall reason

Nestle Health Science has initiated a recall of Solgar Glucosamine Chondroitin, 120 Tablets, in Glass bottle, 12 bottles per case because of error during packaging in which a A Megasorb B-Complex product was filled into bottles labeled as Glucosamine_Chondroitin MSM.

Recall details

Recall number
F-0803-2024
Event ID
93707
FDA status
Terminated
Initiated
Dec 22, 2023
Reported
Feb 7, 2024
Classified
Jan 26, 2024
Terminated
Mar 26, 2024
Quantity
612 bottles
Location
Bridgewater, NJ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

The recalled product was distributed to the following states: NY, IN, PA, TX, TN, NV

FDA source record · F-0803-2024

Data updated September 16, 2026. View official FDA data ↗

Follow official FDA and manufacturer guidance.